MedTrace Logo

Effects of Caffeine on Methacholine Challenge and Exhaled Nitric Oxide Levels.

NCT01057875 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-10-07

No results posted yet for this study

Summary

To investigate whether or not the ingestion of caffeine with alter airway responsiveness to methacholine and/or change the level of exhaled nitric oxide.

Conditions

Interventions

OTHER

caffeine

Starbuck's Grande Pike Roast coffee

OTHER

No caffeine

Starbuck's Grande Pike Roast Decaffeinated Coffee

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Donald W Cockcroft, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057875 on ClinicalTrials.gov